Canada - TSX:HCG - CA4369131079 - Common Stock
The current stock price of HCG.CA is 44.26 CAD. In the past month the price increased by 1.26%. In the past year, price increased by 57.79%.
Symbol | Company Name | TA | FA | PE | Market Cap |
---|---|---|---|---|---|
TF-DB-F.CA | TIMBERCREEK FINANCIAL CO | 195.28 | 8.56B | ||
TF-DB-D.CA | TIMBERCREEK FINA | 188.68 | 8.28B | ||
TF-DB-E.CA | TIMBERCREEK FINANCIAL CO | 186.17 | 8.16B | ||
AI-DB-G.CA | ATRIUM MORTGAGE INV CORP | 96.23 | 4.77B | ||
AI-DB-F.CA | ATRIUM MORTGAGE INV CORP | 95.66 | 4.74B | ||
AIdbf.CA | 95.66 | 4.74B | |||
FC-DB-J.CA | FIRM CAP MTG INV CORP | 97.3 | 3.68B | ||
FC-DB-K.CA | FIRM CAP MTG INV CORP | 97.09 | 3.67B | ||
FC-DB-L.CA | FIRM CAP MTG INV CORP | 96.81 | 3.66B | ||
FN.CA | FIRST NATIONAL FINANCIAL COR | 15.67 | 2.88B | ||
FN-PR-A.CA | FIRST NATIONAL FINANCIAL - FNCN 2.895 PERP | 7.03 | 1.29B | ||
FN-PR-B.CA | FIRST NATIONAL FINANCIAL - FNCN 4.46 PERP | 6.96 | 1.28B |
Home Capital Group, Inc. operates as an investment holding company with interests in providing loan and trust services. The company is headquartered in Toronto, Ontario and currently employs 836 full-time employees. Home Trust is a federally regulated trust company offering residential and non-residential mortgage lending, securitization of residential mortgage products, consumer lending and credit card services. In addition, Home Trust and its wholly owned subsidiary, Home Bank offer deposits through brokers and financial planners, and through a direct-to-consumer brand, Oaken Financial. Its mortgage lending includes classic single-family residential lending, insured residential lending, residential commercial lending, and non-residential commercial lending. Its consumer lending loan portfolio comprises credit cards, lines of credit and other consumer retail loans. In addition, the Company manages a treasury portfolio to support liquidity requirements and invest excess capital.
Home Capital Group Inc
Suite 2300, 145 King Street West
TORONTO ONTARIO M5H 1J8 CA
CEO: Yousry Bissada
Employees: 836
Phone: 14163604663.0
The current stock price of HCG.CA is 44.26 CAD.
The exchange symbol of Home Capital Group Inc is HCG and it is listed on the Toronto Stock Exchange exchange.
HCG.CA stock is listed on the Toronto Stock Exchange exchange.
9 analysts have analysed HCG.CA and the average price target is 44.88 CAD. This implies a price increase of 1.4% is expected in the next year compared to the current price of 44.26. Check the Home Capital Group Inc stock analysts ratings, price target forecast and up-and down grades for more detailed information.
Home Capital Group Inc (HCG.CA) has a market capitalization of 1.69B CAD. This makes HCG.CA a Small Cap stock.
Home Capital Group Inc (HCG.CA) currently has 836 employees.
Home Capital Group Inc (HCG.CA) has a support level at 44.04 and a resistance level at 44.27. Check the full technical report for a detailed analysis of HCG.CA support and resistance levels.
The Revenue of Home Capital Group Inc (HCG.CA) is expected to grow by 22.24% in the next year. Check the estimates tab for more information on the HCG.CA EPS, Sales, EBIT and EBITDA future analyst estimates.
There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:
Home Capital Group Inc (HCG.CA) has a dividend yield of 1.36%. The yearly dividend amount is currently 0.6. Check the full fundamental report for a detailed analysis of HCG.CA dividend history, reliability and sustainability.
Home Capital Group Inc (HCG.CA) will report earnings on 2022-02-17.
The PE ratio for Home Capital Group Inc (HCG.CA) is 9.14. This is based on the reported non-GAAP earnings per share of 4.84 and the current share price of 44.26 CAD. Check the full fundamental report for a full analysis of the valuation metrics for HCG.CA.
ChartMill assigns a technical rating of 7 / 10 to HCG.CA. When comparing the yearly performance of all stocks, HCG.CA is one of the better performing stocks in the market, outperforming 93.24% of all stocks.
ChartMill assigns a fundamental rating of 4 / 10 to HCG.CA. HCG.CA has a medium profitability rating, but doesn't score so well on its financial health evaluation.
Over the last trailing twelve months HCG.CA reported a non-GAAP Earnings per Share(EPS) of 4.84. The EPS increased by 16.63% compared to the year before.
Industry Rank | Sector Rank | ||
---|---|---|---|
PM (TTM) | 32.48% | ||
ROA | 0.76% | ||
ROE | 10.5% | ||
Debt/Equity | 2.66 |
9 analysts have analysed HCG.CA and the average price target is 44.88 CAD. This implies a price increase of 1.4% is expected in the next year compared to the current price of 44.26.
For the next year, analysts expect an EPS growth of 52.54% and a revenue growth 22.24% for HCG.CA